Clinical Trial Update: Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating a coadministered ceftaroline fosamil and NXL104 regimen versus doripenem in adults with complicated urinary tract infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection

Drugs mentioned

• Doripenem (Doribax) (doripenem)
• NXL104 (NXL104)
• ceftaroline fosamil (Teflaro) (ceftaroline fosamil)

Snippet

Sponsor: Forest Laboratories | Conditions: Urinary Tract Infections | Phase 2 | Status: COMPLETED